#news #biotech Eli Lilly, Roche’s Alzheimer’s prospects, including flops, boosted in light of FDA’s Aduhelm approval: analysts

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly, Roche’s Alzheimer’s prospects, including flops, boosted in light of FDA’s Aduhelm approval: analysts .Eli Lilly, Roche’s Alzheimer’s prospects, including flops, boosted in light of FDA’s Aduhelm approval: analysts
badams
Fri, 06/11/2021 – 04:24

from FierceBiotech: Biotech https://ift.tt/3gcrssx